DERMATOLOGY UPDATE FALL 2022 Photo Gallery
DERMATOLOGY UPDATE FALL 2022 Speakers
Dermatologist, Ajax, ON
Dr. David Adam is the Medical Director of Baywood Dermatology. He is also the Lead Investigator at CCA Medical Research, a center for advanced dermatologic therapeutics.
Dr. Adam is an Assistant Professor at the University of Toronto, Faculty of Medicine. He is also on staff at St. Michael’s Hospital.
Dr. Adam received his medical degree at the University of Toronto graduating with honors. He completed his residency at the University of British Columbia in the Department of Dermatology and Skin Science, serving as Chief Resident.
Dr. Adam is also the President of the Dermatology Association of Ontario, serves as a reviewer for several medical journals and regularly publishes in peer reviewed journals.
Dermatologist, Toronto, ON
Dr. Beach is a dermatologist practicing medical and cosmetic dermatology in Toronto. She opened DermAtelier on Avenue in the Avenue-Lawrence area of the city just over 2 years ago. Her goal is to provide the best possible dermatologic care for people, across skin tones and skin types.
She enjoys treating a range of skin conditions and understands that what often starts off as medical in nature, can develop sequelae that require treatments that are cosmetic in nature and delivery.
In addition to her Dermatology practice, Dr Beach collaborates with medical students and residents in select research projects, teaches residents at Women's College hospital Hair Loss clinic and highlights the knowledge and expertise of dermatologists in her various online, print and television media appearances.
Ines Benassou is the Medical Communications Manager for CeraVe Canada. She has completed a Master’s degree in Molecular Biology from Sherbrooke University and published articles in cancer research and neuroimmune disorders.
Ms Benassou actively works to bring forth the ‘therapeutic skincare for all’ mission of CeraVe by developing more inclusive educational content, working in close collaboration with Canadian dermatologists
Dermatologist, Toronto, ON
Tiffany Chen, MD, FRCPC, DABD, is a board-certified dermatologist in Canada and the United States. She received her Honours B.Arts Sc. and MD from McMaster University. She completed her dermatology residency at the University of Toronto and served as chief resident in her final year. Dr. Chen is a lecturer at the University of Toronto and an associate dermatologist at Sunnybrook Health Sciences Centre.
Dermatologist, Ville de Québec, QC
Dr. Joël Claveau is a dermatologist, specialized in the diagnosis and treatment of Melanoma and Skin Cancers, and an Associate Professor with the Department of Medicine at Laval University where he completed his Medical Study and Internal Medicine training. He did his residency in Dermatology at McGill University and subsequently worked at the Melanoma Clinic at the Royal Victoria Hospital in Montreal, Quebec. He is a diplomat of the American Board of Dermatology and is a member of a number of Medical Societies including the American Academy of Dermatology and the International Dermoscopy Society. He has received awards including
Honorary Member of La Société Française de Dermatologie, the Dermatologist’s Volunteer Award of the Canadian Dermatology Association (CDA) for his work on the prevention of skin cancers and the CDA
Symposium of the year at two occasions (Dermoscopy).
Since 1996, he has been the Director of the Melanoma and Skin Cancer Clinic at Le Centre Hospitalier Universitaire, Hôtel-Dieu de Québec, and worked in
Public Health for the province of Québec especially on the new Tanning Bed Legislation. He participated to the publication of papers in peer-review journals including work on melanoma, skin cancers and sunscreens. He is actively involved in a various Continuing Medical Education events and investigator in many clinical trials on advanced and metastatic melanoma.
La Roche-Posay Canada
Nour Dayeh is the medical communications manager for La Roche-Posay Canada and Dermablend Pro. Dr Dayeh, completed her PhD in Biomedical Sciences from the University of Montreal, and has research experience and published work in Oncology, Cardiology, and dermatology. in addition to her current role as the medical communications manager, Dr Dayeh maintains research work in the field of cutaneous toxicities associated with oncology treatments.
Dermatologist, Boston, MA
Dr. Dover graduated as the silver medalist, Magna cum Laude from the University of Ottawa. His dermatology training was received at the University of Toronto followed by research fellowships at St. John’s Hospital for Diseases of the Skin at the University of London in London, England, and a two-year photomedicine fellowship at Harvard Medical School. Dr. Dover is a former Associate Professor of Dermatology at Harvard Medical School, was Chief of Dermatology at the New England Deaconess Hospital for over ten years and also Associate Chairman of Dermatology at Beth Israel Deaconess Medical Center. He is Associate Clinical Professor of Dermatology at Yale University School of Medicine, and Associate Professor of Dermatology at Brown Medical School. Dr. Dover is a co-director of SkinCare Physicians in Chestnut Hill, Massachusetts. Dr.
Dover is the author of over 550 scientific publications and he has co-authored and edited over 55 textbooks. He is founding editor of Journal Watch for Dermatology. Dr. Dover has received many honors including repeated nominations for “teacher of the year” at Harvard Medical School. He was honored with the Leon Goldman Award, the Ellet Drake award, and the Caroline and William Mark Memorial Award of the American Society for Laser Medicine and Surgery and was honored for his work in laser surgery by the Sturge Weber Foundation at its 20th Annual Gala. He has received several presidential citations from both the American Society of Lasers in Medicine and Surgery and the American Society for Dermatological Surgery. Dr. Dover is past president of the American Society for Lasers in Medicine and Surgery, the American Society for Dermatologic Surgery, and the New England Dermatology Society. He is married to Dr. Tania Phillips and has 2 daughters, Sophie and Isabel.
Dermatologist, Toronto, ON
Dr. Patrick Fleming is a certified dermatologist with clinical interests in inflammatory skin disease, infectious disease, and public health. He is an Assistant Professor at the University of Toronto where he teaches medical students and residents. He completed residency at the University of Toronto where he was Chief Dermatology Resident and concurrently completed the Global Clinical Scholars program in Clinical Trials at Harvard Medical School. He holds a Master’s degree in Community Health, a Graduate Certificate in Medical Education, and was the Gold Medalist in medical school. He has held national research funding from the Canadian Institutes for Health Research and Canadian Dermatology Foundation. He is an Associate Editor the Journal of Cutaneous Medicine and Surgery & serves on the Board of Governors for the Canadian Dermatology Foundation. Dr. Fleming’s research background includes systematic reviews and he is an investigator for dermatology clinical trials.
Dermatologist, Edmonton, AB
Dr. Parbeer Grewal completed his Bachelor of Science undergraduate degree at the University of Alberta with a specialization in Psychology and graduated with distinction. He completed his Doctorate of Medicine degree at the University of Alberta and graduated with Special Training in Research. He completed dermatology training at the University of Alberta and became a Fellow of the Royal College of Physicians and Surgeons of Canada and a board-certified Fellow of the American Academy of Dermatology.
Dr. Grewal is an Associate Clinical Professor within the University of Alberta’s Faculty of Medicine - Dermatology. In addition to working at Rejuvenation, he is a consulting physician for the University of Alberta Hospital, the Royal Alexandra Hospital, the Grey Nuns Hospital and the Misericordia Hospital. Dr. Grewal participated in over 60 clinical research trials for a multitude of dermatology conditions and medications. Additionally, Dr. Grewal serves on multiple national and international scientific advisory boards, is a distinguished peer reviewer for medical journals and has published both journal articles and book chapters in dermatology.
He has specific interests in psoriasis, acne, eczema, warts, skin cancers, rashes and moles. He offers a wide range of topical and systemic therapy along with surgical and aesthetic services.
Dermatologist, London, ON
Dr. Lyn Guenther is a Professor of dermatology at Western University in London Ontario Canada, Fellow of the College of Physicians and Surgeons of Canada (FRCPC) and is Board-Certified in the United States. She received her MD degree from the University of Western Ontario and completed her dermatology residency training at the University of Michigan, Ann Arbor Michigan, USA. She has been involved in more than 190 research projects since 1980 and is the president of Guenther Research Inc.
Dr. Guenther was chair of the Division of Dermatology at Western University from 1991 to 1999 and President of the Canadian Society for Dermatologic Surgery from 2001 to 2003. She chaired the Canadian expert panel for the treatment of moderate-to-severe psoriasis in 2004, was a member of the expert panel for the 2009 and 2016 Canadian Psoriasis Guidelines. She was also a member of the 2015 Canadian Non-melanoma Skin Cancer Guidelines Committee.
Dr. Guenther has more than 200 publications, is a reviewer for a number of journals, and has been the medical editor of Dermatology Times of Canada since 1998. She has lectured to medical students at St. George’s University in Grenada and has acted as an advisor to Health Canada, the Drug Quality and Therapeutics Committee for Ontario, the Canadian Medical Protective Association, the Canadian Cancer Society, and many pharmaceutical companies.
Dr. Guenther enjoys teaching and lectures locally, provincially, nationally and internationally. She has won a certificate of appreciation for excellence in undergraduate medical education and since 2007, has been voted “Best Doctor” by peers. In 2022, she was selected by peers to 2022’s Women in Dermatology Honour Roll.
New York, NY
George Han, MD, PhD, is an Associate Professor in the Department of Dermatology at the Donald and Barbara Zucker School of Medicine at Hofstra / Northwell, where he leads efforts in clinical research and teledermatology. He is the current Vice President of the Dermatologic Society of Greater New York, a member of the board of directors of the New York State Society of Dermatology and Dermatologic Surgery, a member of the Medical Board of the National Psoriasis Foundation, and an Associate of the International Eczema Council.
Dr. Han is a nationally recognized lecturer and researcher in numerous areas including atopic dermatitis, psoriasis, and teledermatology. To date, he has over 60 publications in well-respected journals such as the Journal of the American Academy of Dermatology, the Journal of Investigative Dermatology, the British Journal of Dermatology, the Journal of Infectious Diseases, and the American Journal of Pathology, as well as several book chapters and patents. He remains active in both basic science research and clinical trials, serving as Principal Investigator in trials encompassing clinical areas such as Psoriasis, Atopic Dermatitis, Hidradenitis Suppurativa, Acne, and Vitiligo.
Dermatologist, Calgary, AB
Dr. Hawkins is a dual board certified dermatologist practicing in Calgary and Okotoks, Alberta. She splits her time evenly between medical and cosmetic dermatology. Nicole completed an undergraduate honors thesis in Nutrition at Acadia University and her MD at Queen’s School of Medicine.
During medical school, she was Chair of the Ontario Medical Students Association for two years. She completed her residency in Dermatology at the University of Toronto in 2014 before moving to Saskatoon where she co-founded the province’s largest dermatology clinic, encompassing medical and cosmetic dermatology, and clinical research. This business was sold in 2019, and she moved home to Calgary.
Dr. Hawkins’ hobbies include reading, running, skiing and spending the summers at the cottage with her young family.
Dermatologist, Toronto, ON
Marissa Joseph, MSc, MD, FRCPC ( Pediatrics), FRCPC ( Dermatology)
Dr. Marissa Joseph graduated with a combined BSc (Honours) in Biochemistry and Biology from Dalhousie University, and then completed medical school at Dalhousie University. She is a board certified Pediatrician and Dermatologist after completing Pediatric training at the Hospital For Sick Children, following with a Dermatology residency at the University of Toronto. She completed a MSc in Community Health at the Dalla Lana School of Public Health.
Dr. Joseph is full time academic faculty at the University of Toronto. She has received and has been nominated for teaching awards in both undergraduate and postgraduate medical education. Dr. Joseph is the Medical Director of the Ricky Kanee Schachter Dermatology Centre at Women's College Hospital. She also works at the Hospital For Sick Children where she manages children with complex dermatologic disease in outpatient and inpatient settings, as well as a pediatric laser treatment program. Dr. Joseph enjoys her diverse practice in general adult, pediatric and surgical dermatology. Her clinical and research interests include inflammatory skin disorders such as psoriasis, atopic dermatitis, and hidradenitis suppurativa; genodermatoses, and equity, diversity and inclusivity.
Dermatologist, Ottawa, ON
Dr. Mark Kirchhof is the Division Head of Dermatology in the Faculty of Medicine at the University of Ottawa and The Ottawa Hospital. After receiving his Bachelor of Science in molecular biology from McMaster University, Dr. Kirchhof completed his medical degree and PhD at Western University in London, Ontario. His PhD research involved studies of the signalling pathways important to immune system regulation. He then went on to complete his dermatology residency at the University of British Columbia in Vancouver, British Columbia.
Until August 2017, Dr. Kirchhof was the Education Director at Queen’s University in Kingston, Ontario, where he coordinated and led undergraduate, post-graduate and continuing medical education activities. He has published over 65 peer-reviewed papers and maintains a keen interest in clinical and bench-to-bedside research. He has been invited to speak at local, national and international meetings. His clinical interests are varied and he sees both pediatric and adult patients.
Dermatologist, Markham, ON
Dr. John Kraft is a board-certified dermatologist who practises at Lynde Institute for Dermatology in Markham. He is a member of the Canadian Dermatology Association where he has served on the Membership and Awards Committee.
Dr. Kraft is a GTA Regional Representative for the Dermatology Association of Ontario. He is a reviewer for the Journal of Cutaneous Medicine and Surgery.
Dr. Kraft completed his HBSc (0T2), Medical Degree (0T6) and Residency in Dermatology at the University of Toronto in 2011 where he served as Chief Resident.
Dr. Kraft acts as an investigator for many clinical trials including those for novel skin therapeutics at Lynderm Research and Probity Research. He has published papers in peer-reviewed journals and has spoken at international and national dermatology scientific conferences.
Dr. Kraft enjoys teaching medical students and resident physicians from across Ontario and has won the Markham Family Medicine Teaching Unit Award for Teaching Excellence in 2014 and 2017.
Dermatologist, Toronto, ON
Dr. Perla Lansang is a full-time staff dermatologist and associate professor in the Division of Dermatology, University of Toronto where she is the Division Head of Dermatology at Sunnybrook Health Sciences Centre. She is also cross appointed at the Section of Paediatric Dermatology at the Hospital for Sick Children, and the Division of Obstetric Medicine at Sunnybrook Health Sciences Centre.
She completed her medical school and dermatology residency at the University of the Philippines-Philippine General Hospital. Having done fellowships in paediatric dermatology at The Hospital for Sick Children and in advanced medical dermatology at Sunnybrook Health Sciences Centre, Dr. Lansang’s practice is a mixture of pediatric, adolescent, and adult dermatology, with a special focus on psoriasis, atopic dermatitis, cutaneous lymphoma, pregnancy dermatoses, and general medical dermatology. She has a special interest in immune-mediated skin diseases and has extensive clinical and research experience in many areas of immunodermatology.
Dermatologist, Vancouver, BC
Dr. Li is a double board-certified cosmetic and medical fellowship-trained dermatologist, and a Clinical Instructor in the Department of Dermatology & Skin Science at the University of British Columbia. She practices in Vancouver and Surrey, BC.
She has published numerous peer-reviewed articles, and has been an invited lecturer at various national and international conferences. Dr. Li is an active committee member of the American Society for Laser Medicine & Surgery and the American Society for Dermatologic Surgery. She is a regular voice to local and national media.
Dermatologist, Ottawa, ON
Dr. Lipson is a medical dermatologist in Ottawa practising at West Ottawa Specialty Care. She is a lecturer at the University of Ottawa and an associate physician at The Ottawa Hospital and the Children’s Hospital of Eastern Ontario (CHEO). She serves as a committee member for the Ottawa Dermatology Clinical and Scientific Biannual Meeting, the Royal College of Physicians and Surgeons of Canada Subspecialty Committee for Dermatology and The Acne and Rosacea Society of Canada. Her clinical interests include immune-mediated inflammatory diseases, hormonal acne and skin cancer.
Dermatologist, Markham, ON
Dr. Carrie Lynde is a board-certified dermatologist who practises at Lynde Institute for Dermatology in Markham. She is a member of the Canadian Dermatology Association.
Dr. Lynde completed her HBSc (0T2), LLB (UWO 2005), Medical Degree (0T9) and Residency in Dermatology at the University of Toronto in 2014. Dr Lynde completed a fellowship in Laser and Esthetic Medicine at the University of Toronto in 2015.
Dr. Lynde acts as an investigator for clinical trials including those for novel skin therapeutics at Lynderm Research and Probity Research. She has published papers in peer-reviewed journals and has spoken at national dermatology scientific conferences.
Dermatologist, Markham, ON
Dr. Charles Lynde is an Associate Professor in the Department of Medicine at the University of Toronto and holds a clinical teaching position at the University Health Network. He is the Medical Director of Lynde Institute for Dermatology and Lynderm Research. The Lynde Institute for Dermatology is a full service, interdisciplinary dermatology clinic. After receiving his B.Sc. and MD, degrees at the University of Toronto, Dr. Lynde studied Dermatology at the University of British Columbia and the University of Toronto, receiving his Board Certification (Canada and USA) in 1983.
Lynderm Research is under the guidance of Dr. Lynde as principal investigator for more than 30 years and over 300 clinical trials and is actively involved in the management of psoriasis, rosacea, onychomycosis, acne and atopic dermatitis among other dermatological conditions. Dr. Lynde has authored over 200 peer-reviewed articles.
Dr. Lynde has served in various roles for the CDA and AAD, including President of the Canadian Dermatology Association. He is the Editor of the CDA eBulletin and sits on the editorial boards of several journals and provides extensive consulting as well as being on the advisory boards of many pharmaceutical companies. Dr. Lynde is a frequent guest speaker both nationally and internationally at various dermatological conferences. Recognizing the need for external education he is committed to the training of new and current healthcare professionals in his community and residents through the university program.
Dermatologist, Kingston, ON
Dr. Sonja Molin is an Associate Professor and Chair of the Division of Dermatology, Department of Medicine at Queen’s University. Dr. Molin completed her training in Dermatology and Allergology at the Ludwig Maximilian University in Munich, Germany, where she worked for 11 years before she joined Queen’s University in 2018. The main focus of her clinical expertise and research are inflammatory skin diseases, mainly hand eczema and psoriasis, contact allergy and occupational dermatology. She has published more than 50 peer-reviewed articles and book chapters and has been awarded a number of research prizes. Dr. Molin is an author of the 2022 update of the European Society of Contact Dermatitis guidelines on the diagnosis and treatment of hand eczema and is also involved with the American Society of Contact Dermatitis.
Dermatologist, Montreal , QC
Elena Netchiporouk, MD, MSc, FRCPC, FCDA
Dr. Netchiporouk obtained her MD degree from Université de Montréal and completed her MSc in Experimental Medicine and residency training at McGill University. She has been appointed Assistant Professor of Dermatology in 2018 and Assistant Professor of Experimental Medicine and Junior Scientist within the Infectious Diseases and Immunity in Global Health (IDIGH) Program at McGill in 2020. Her clinical and research focus is immune-mediated diseases in dermatology with particular focus on mast cell disorders (e.g. urticaria, mastocytosis), skin fibrosis (e.g. morphea) and adult genodermatoses. Her research is supported by Canadian Dermatology Foundation, Fonds de Recherche Santé Québec, Canadian Institutes of Health Research, and McGill University grants.
Dermatologist, Ottawa, ON
Dr. Elena Pope is a Professor in the Department of Paediatrics at the University of Toronto. In 2003, she became the Head of the Section of Dermatology. Her clinical interests are in medically complex and rare pediatric dermatology diseases. Dr. Pope has instituted innovative approaches to the care of these patients by establishing/running interdisciplinary clinics in Epidermolysis Bullosa, Cutaneous T-cell lymphoma, Vascular Tumors, Morphea and Genodermatoses, some of them unique to Canada and abroad. Her research interests are aligned to her clinical interests and focus on advancing the field of Paediatric Dermatology by expanding the therapeutic repertoire of common and orphan diseases, developing new outcome measures and participation and international leadership in collaborative research. Dr. Pope is committed to education in all its aspects and has been the recipient of local and international teaching and mentorship awards.
Dr. Pope has held executive leadership positions in PeDRA (Pediatric Dermatology Research Alliance), is the current Committee Chair for Strategic Development of Society for Pediatric Dermatology (SPD) and Executive Board member of the International Society for Pediatric Dermatology (ISPD).
Dermatologist, Calgary, AB
Dr. Prajapati completed his dermatology residency at the University of Alberta, earning certification in both Canada and the United States. He then pursued an additional 1-year fellowship in pediatric dermatology at Harvard Medical School. Dr. Prajapati has received 20 major awards; authored 1 textbook chapter; published 43 peer-reviewed manuscripts in print or electronic format; and presented 48 abstracts at scientific meetings regionally, nationally, as well as internationally. He also conducts clinical trials for both adults and children, with participation in 69 studies as an investigator or steering committee member.
Dr. Prajapati is a Clinical Associate Professor at the University of Calgary as well as co-founder and co-director of Skin Health & Wellness Centre, Dermphi Centre, and Dermatology Research Institute. Additionally, he has started several subspecialty initiatives, including multidisciplinary pediatric morphea, pediatric scleroderma, and pediatric psoriasis clinics in Calgary as well as rapid access psoriasis and rapid access eczema clinics in Calgary plus rural outreach psoriasis and rural outreach eczema clinics Medicine Hat.
Dermatologist, Quebec City, QC
Dr. Ringuet is a board-certified dermatologist who practices in Quebec City with a focus on clinical trials.
After his bachelor degree in biology, Dr. Ringuet completed his medical training (MD) at Laval University in Quebec City. He also performed his post graduate studies in dermatology in his alma mater from which he graduated in 2020. Additionally, and considering his keen interest in research, Dr. Ringuet completed throughout his medical training a master in experimental medicine (MSc) in the field of skin bioengineering at the Centre de Recherche en Organogénèse Expérimentale de l’Université Laval (LOEX).
In collaboration with the center founder, Dr. Yves Poulin, Dr. Ringuet now leads his dedicated team of the Centre de Recherche Dermatologique du Québec Métropolitain (CRDQ) in allowing Quebec’s patients to access top quality and innovative clinical research focused on dermatological diseases. Dr. Ringuet’s research interest are mainly psoriasis and its variants, atopic dermatitis, vitiligo and alopecia areata.
Dermatologist, Toronto, ON
Dr. Skotnicki received her undergraduate degree in microbiology and immunology from the University of Toronto. She completed medical school at the same institution, graduating Alpha Omega Alpha. She went on to complete her dermatology training at the University of Ottawa, and was awarded her fellowship in Dermatology by the Royal College of Physicians and Surgeons of Canada in June 1997. She is a Diplomat of the American Board of Dermatology and is an Assistant Professor at the University of Toronto, Department of Medicine in the Divisions of Dermatology and Occupational Health. Her memberships include the Canadian Medical Association, Canadian Dermatology Association, American Dermatology Association and American Contact Dermatitis Society. She is a past Board member of the Canadian Dermatology Association and a past examiner for the Royal College of Physicians and Surgeons in the specialty Dermatology.
Dr. Skotnicki has been practicing in the Toronto area since 1997. She is currently on staff at St. Michael’s Hospital as a Consultant Dermatologist. At St. Michael’s she is a member of the Occupational Disease Specialty Program ODSP, and is responsible for seeing complex Allergic and Occupational skin diseases. A leading expert in Allergic Skin Disease, she is one of a handful of dermatologists in Canada with a sub-specialty interest in Allergic Contact Dermatitis and Patch or Allergy Skin Testing. She is an also a consultant for the Workplace Safety Insurance Board and the WSIAT Workers Safety and Insurance Appeals Tribunal.
Active in research and education, Dr. Skotnicki has been teaching University of Toronto Dermatology, Allergy and Family Medicine residents at her St. Michael’s Hospital clinic since 1999. She is also a member of CREOD, the Centre for Research Expertise in Occupational Disease, and has published articles on different aspects of Allergic Skin Disease.
Dr. Skotnicki published her first popular science book “Beyond Soap” with Penguin Random House in Canada and the US. It is a bestseller in Canada and was written to help the public navigate the increase in skin reactions to cosmetics and skincare. It also explains in detail the rise in eczema and sensitive skin in developed society and offers science-based explanations. It has been translated into Russian, Czech and Vietnamese.
Dermatologist, Windsor, ON
Dr. Tan received his medical degree from Queen’s University in Kingston, Ontario and trained in internal medicine at the University of Toronto and in dermatology at University of British Columbia and University of Michigan. His general dermatology and aesthetic dermatology practices are in Windsor Ontario Canada. He conducts clinical trials research at Windsor Clinical Research, a clinical trials site in dermatology. Aside from industry grants, he has received research funding from the Canadian Dermatology Foundation and the National Institutes of Health Research.
Research focus includes acne, acne scars and rosacea. Additional interests include outcome measurements and informed shared decision making in dermatology. We have developed 3 patient decision aids in dermatology – acne, psoriasis and hidradenitis suppurativa – available at www.informed-decisions.org
Dr. Tan chairs the working group on clinical practice guidelines of the Canadian Dermatology Association, the rosacea international consensus group (ROSCO) and the acne core outcomes research network (ACORN). He has been an associate editor of the Journal of the American Academy of Dermatology and the British Journal of Dermatology. Over the past 3 decades, Dr. Tan has authored/co-authored more than 100 peer-reviewed publications.
Dermatologist, Fredericton, NB
Dr. Turchin has a Bachelor of Science degree from the University of Alberta. She did her medical training at the University of Calgary and completed Dermatology residency at McGill University. Dr. Turchin is board certified in Dermatology in both, Canada and United States. Dr. Turchin holds memberships with Canadian Dermatology Association, American Academy of Dermatology and European Academy of Dermatology. She continuously keeps herself up-to-date with the latest medical discoveries by frequently attending national and international conferences and presenting at scientific meetings. Dr. Turchin is interested in medical innovation and is involved in clinical trials.
Dr. Turchin is committed to medical education as Assistant Professor at Dalhousie and Memorial Universities. She preceptors medical students and residents and commonly presents on dermatology topics to other physicians. She also partakes in public education forums for patients.
Dermatologist, Vancouver, BC
Dr. Marcie Ulmer is a Royal College and American Board of Dermatology certified dermatologist. She is a Clinical Instructor at the Department of Dermatology and Skin Science, University of British Columbia, where she completed her dermatology residency. Originally from the Prairies she completed her Bachelor of Science (Honours), Bachelor of Science (Medicine) as well as her Medical Degree at the University of Saskatchewan. Her comprehensive full time practice in Vancouver at Pacific Derm encompasses both medical and aesthetic dermatology and she is actively involved in clinical research.
Dermatologist, London, UK
Professor Sean Whittaker is a Consultant Dermatologist at St Johns Institute of Dermatology, Guys and St Thomas’ Hospital, with clinical and academic interests in cutaneous lymphoma and melanoma.
He was appointed Professor of Cutaneous Oncology in the School of Basic and Medical Biosciences at Kings College London in 2007, and has published extensively in peer-reviewed journals on the
molecular pathogenesis of cutaneous lymphomas.
He is currently Medical Director for the NHS South East England Genomic Medicine Service and Laboratory Hub and Co-Director of the King's Health Partners (KHP) Comprehensive Cancer Centre for South East London.
His previous leadership roles include Clinical Director for the Specialist Ambulatory Directorate at Guys and St Thomas’ NHS Foundation Trust; Co-Lead for the Genetics, Rheumatology, Infection, Immunology and Dermatology (GRIID) Clinical Academic Group; Chair for NHS England Clinical Reference Group (CRG) and Lead for Skin Cancer; Chair of the European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force; President of the International Society of Cutaneous Lymphomas (ISCL).
Dermatologist, Winnipeg, MB
Dr. Marni C. Wiseman began her Dermatology practice in Winnipeg, Manitoba in 2001. In addition to her responsibilities as an Associate Professor and Section Head of Dermatology at the Faculty of Medicine at the University of Manitoba, Dr. Wiseman spends most of her days at her Private Medical Practice as the Medical Director of SKiNWISE DERMATOLOGY.
Dr. Wiseman’s areas of clinical and research interest include psoriasis, atopic dermatitis, hidradenitis suppuritiva, acne, and aesthetic dermatology. She is a Principal Investigator at Wiseman Dermatology Research and has participated in hundreds of clinical trials.
Dr. Wiseman is a frequent supervisor and mentor for medical students and residents. She is extensively published in areas of inflammatory skin disease, photodermatosis, and cutaneous malignancy.
Dr. Wiseman’s community commitments are extensive and include involvement with the Canadian Dermatology Association Sun Awareness program. She is an editor of the Journal of Cutaneous Medicine and Surgery, and was the chair of the Skin Cancer Disease Site Group at CancerCare Manitoba for 15 years. Dr. Wiseman holds regular outreach skin cancer screening clinics in rural locations in Manitoba, has been featured in many news stories, and regularly presents at meetings and congresses nationally and internationally.
Dermatologist, Toronto, ON
Dr. Geeta Yadav, MD, MHS, FRCPC
Medical Director & Founder, FACET Dermatology
Dr. Geeta Yadav is the founder of FACET Dermatology in Toronto. She is board-certified dermatologist who trained at University of Toronto, Johns Hopkins and the Northern Ontario School of Medicine. Dr. Yadav is an expert in both medical and cosmetic dermatology with a large and growing medical practice that specializes in atopic dermatitis, psoriasis, and skin cancer. She has a special interest in skin of color and has been quoted in numerous main stream publications including the New York Times, Wall Street Journal, Allure, Vanity Fair and Cosmopolitan. She has a regular presence on Instagram, Facebook and LinkedIn and tries to use these platforms for education and awareness on a variety of topics.
Dermatologist, Toronto, ON
Dr. Jensen Yeung obtained a B.Sc. (Honours) with a gold medal for the highest GPA in the graduating class in all faculties and his MD from McMaster University in 2001. In the same year, he began his dermatology residency training at the University of Toronto. During his residency training, he spent 6 months in Australia, New York, and Boston gaining clinical experience and acquiring the newest knowledge in the field of melanoma and dermoscopy from leading experts. In 2005, he was selected by the residency program as the co-chief resident for the year. Having obtained his board certification from the Royal College of Physicians and Surgeons of Canada in 2006, he joined the Faculty of Dermatology at the University of Toronto, where he ran teaching clinics at both Women’s College Hospital and the Sunnybrook Health Sciences Centre. In 2007, he was promoted to the position of medical director for the RKS Dermatology Program at Women’s College Hospital, where he ran a melanoma, psoriasis, and General Dermatology clinic. In 2013, he switched from RKS to PERC and took on the new role as the medical director of PERC (phototherapy education and research centre) where he runs weekly psoriasis/phototherapy clinic. In 2014, he and Dr. Dana Jerome started a monthly combined psoriasis/psoriatic arthritis clinic at PERC. In 2011, he joined Dr. Kim Papp’s research facility in Waterloo and has participated in close to 200 phase 1 to 4 clinical trials. He has also supervised and mentored many research students and residents, which has led to around 130 peer-reviewed publications. He is an associate editor at JCMS and Canadian Dermatology Today. He has received a number of teaching awards including the best resident teacher award in 2005, the 2008 Women’s College Hospital Department of Medicine Postgraduate Teaching Award and the 2009 University of Toronto Dermatology Postgraduate Program Staff Teaching Award
Dermatologist, Vancouver, BC
Dr Youwen Zhou is a dermatologist scientist and the Director of Research at the Department of Dermatology and Skin Science at University of British Columbia. A board-certified dermatologist in Canada and US, Dr Zhou received his MD from University of Toronto and PhD from Downstate Medical Center in New York. He serves on the editorial board of JAAD and Journal of Cutaneous Medicine and Surgery. He is the Scientific Chair or Canadian Dermatology Foundation and the past president of Canadian Society of Investigative Dermatology. Dr Zhou practices in Vancouver General Hospital where he specializes in the treatment and research of inflammatory, pigmentary, and malignant skin diseases. Dr Zhou also conducts clinical trials and provides consultation on preclinical and clinical development of skin therapeutics.
DERMATOLOGY UPDATE FALL 2022 Program
Opening & Drug Update
- To be familiar with the key dermatological therapeutics of 2022 and what’s in the pipeline for 2023 and beyond
- To translate this information into the changing dermatologic practice
Optimizing Outcomes in Acne Management
In a medical encounter, there are two experts: the clinician, expert in disease and its management and the patient, expert in illness and their own circumstances. A therapeutic relationship is a journey recognizing the expertise of both. This presentation addresses practical aspects of initiating the acne care pathway representing the what, why, when and how aspects of treatment.
- Understand how to engage patients in a brief acne consultation
- List the critical questions that help direct your acne management plan
- Discuss essential aspects to explain at treatment initiation
Management of Adult Female Acne
- Review hormones found in commonly used contraceptives and how they impact acne
- Update on new hormonal contraceptive agents
- Review non-contraceptive options for managing adult female acne
Questions & Answers
Health Skin for Baby: The Role of Oat Emollients for all Skin Tones
- Understand the unique differences of infant skin vs. adult skin.
- Discuss the clinical manifestations of pediatric atopic dermatitis (AD) across skin types, and its impact on quality of life.
- Review the importance of skin directed therapy, highlighting the multifaceted benefits of colloidal oatmeal and the evidence supporting its use in Pediatric Atopic Dermatitis across skin types.
2022 recommendations for prevention of shingles in dermatology patients
- Recognize the clinical manifestations and complications of herpes zoster
- List risk factors for Zoster and postherpetic neuralgia (PHN)
- Recognize the benefit of vaccination to prevent zoster and postherpetic neuralgia
- Discuss when and how to vaccinate your at risk patients against zoster
The Canadian lifetime risk for zoster is 28%, and 50% over age 85. In addition to older age, a family history of zoster, immunosuppression and JAK inhibitors can also increase the risk for zoster. Zostavax was the first available zoster vaccine, but it was discontinued in Canada October 14, 2022. Shingrix is a non-live adjuvanted subunit vaccine which has approval for zoster prevention in immunocompetent individuals ≥ 50 years as well as immunocompromised individuals ≥ 18 years. Two doses of 0.5 ml reconstituted Shingrix IM are recommended given 2-6 months apart in immunocompetent individuals and may be given 1-2 months apart in immunocompromised individuals. It is highly efficacious (>90%) in immunocompetent individuals with a minimal decline in clinical efficacy and humoral and cellular immunity over 10 years of follow-up. It addition it has been shown to prevent postherpetic neuralgia and other zoster complications. The efficacy in immunocompromised individuals is comparable with persistent immunity for at least 1 year. Dermatologists should be proactive in recommending vaccination against zoster.
New evidence supporting the benefits of ceramide-containing cleansers and moisturizers as adjunct therapy in acne vulgaris
- Explore skin barrier dysfunction in acne
- Discuss the benefits and challenges of effective RX therapy in acne
- Present new data showcasing the benefits of ceramide-containing adjunct therapy
Summary/description of the session:
Skin barrier dysfunction plays a role in the pathology, development and severity of acne. Topical acne prescription therapy, while effective, can cause further damage to the skin barrier and lead to irritation and can negatively affect patient treatment adherence. In this presentation, new clinical evidence supporting the benefits of using ceramide-containing cleansers and moisturizers as adjunct therapy will be demonstrated.
Lunch Break & Visit Sponsors
Alopecia Areata: A scoping review on quality of life, mental health, and work productivity.
Targeted Therapies for BRAF-mutant metastatic melanoma
- Review the latest clinical research updates in BRAF-mutant metastatic melanoma
- Discuss the current Canadian treatment paradigm, treatment sequencing, and the impact of evolving treatment strategies
- Acquire practical strategies to optimize targeted therapy treatment management
- Review the cutaneous side effects of targeted therapy used in cancer treatment
The patients perspective on Psoriasis; it’s a pain below the neck!
- Understand the patients’ perspective on their psoriatic disease – Results from the Global Psoriatic Disease Survey (including Canadian patients)
- Highlight key Canadian data on PsA screening approaches & innovative screening tools in real-life setting
- Help Dermatologists differentiate between axPsA and AS to optimize care in patients living with psoriatic disease
Optimizing post-dermatological procedural wound care
- Topical antibiotics in post-procedural wound care
- Allergy concerns in topical wound care
Dermatologists perform >25 M in-office surgical procedures annually. Infection rates after in-office dermatologic procedures range from 0.2% to 2.5%. Additionally reported rates of allergic contact dermatitis to antibiotics ointments are higher than the observed risk of infection. This presentation will review studies that show no difference in infection rates between those treated with topical antibiotics and those treated with petrolatum-based ointments, with a focus on avoiding allergic contact dermatitis for post-surgical wound care.
Exploring the Burden of Vitiligo: the Patient Perspective
- To understand the burden of vitiligo beyond skin
- To discuss factors that affect the level of disease burden in patients
Vitiligo is a chronic autoimmune disease characterized by the destruction of melanocytes, resulting in pale or white patches of skin. It is associated with significant quality-of-life impairment in routine activities, employment, and psychosocial health. This presentation will review the finding from a global, observational, cross-sectional analysis involving 3,541 people diagnosed with vitiligo (n=200 from Canada), with a focus on the patients’ quality life, mental health and treatment experience.
Does seasonal variation impact the efficacy and safety/tolerability of a new topical retinoid in acne management?
- Discuss the significance of the Polymeric Emulsion Vehicle Technology in topical retinoid formulation.
- Analyse the impact of winter and summer seasons on the efficacy and tolerability of a new topical retinoid formulation in acne management.
Breakfast & Visit Sponsors
Deucravacitinib Open Session: PsO Who Are You?
- Differentiate TYK2 inhibitors from JAK inhibitors
- Identify patients with moderate-to-severe psoriasis who are candidates for oral TYK2 inhibitors based on their disease characteristics and medical history
- Apply practical skills to managing patients on TYK2 inhibitors
PsO Who Are You is the extraordinary dermatology conference challenge that provides compelling education for all dermatologists!
THE OBJECT OF THE GAME is to discover the answer to three questions related to the use of existing and emerging oral therapies:
WHO are the patients using oral systemic therapies?
WHAT is their medical and treatment history prior to starting an oral therapy?
WHY is an oral therapeutic an appropriate option for those patients?
THE GAME BOARD features three stellar dermatologists: Dr. David Adam, Dr. Perla Lansang, and Dr. Julien Ringuet. Of the many possible patient scenarios, each opponent will present one character who is eligible for advanced oral therapies.
THE GAME PLAY will begin with each opponent taking turns posing questions on medical history and treatment considerations in order to reveal the details of the patient case.
THE GAME ENDS when one opponent correctly guess the patient description based on the clues given throughout the presentation.
Three dermatologists, three patient profiles. Let the game begin!
Skin Health and Oat Therapy
This session will highlight the history of oat, the data supporting the mechanism of action of oat in emollients and the clinical efficacy and safety of its use in atopic dermatitis and other various skin conditions and populations.
- Identify the components and the multifaceted benefits of colloidal oatmeal and its effect on the moisture barrier.
- Recognize the clinical research highlighting the benefits of colloidal oatmeal in various skin conditions.
Let’s talk GPP!
In the broad category of psoriasis lies many diseases, including the broadly known and prevalent plaque psoriasis, as well as the far less common, and rare, conditions such as guttate, inverse, erythrodermic and pustular psoriasis. Despite sharing the term psoriasis, generalized pustular psoriasis (GPP) is a distinct condition whose disease pathway is different than the far more common plaque psoriasis. This open session will serve to provide a comprehensive review of GPP, including disease mechanisms and patient prevalence/predispositions. The conversation will then dive into the burden of disease and truly call to light the unmet needs that currently exists with patients suffering with GPP. Those in attendance will gain a better understanding of this rare disease.
Lunch Break & Visit Sponsors
Master the New JAK Inhibitors for Moderate to Severe Atopic Dermatitis
- Review the evidence supporting the use of JAK inhibitors in patients with moderate to severe atopic dermatitis
- Define the role of JAK inhibitors to address unmet needs in the treatment of moderate to severe atopic dermatitis
- Gain knowledge on the use of JAK inhibitors through tips and frequently asked questions (FAQs)
Antioxidants for All – all skin types and all skin tones
Vitamin C (L-ascorbic acid), in synergy with other combination antioxidants, have been shown to prevent skin damage from UV and environmental aggressors in the last 3 decades. This is achieved due to its precise formulation that maximizes its absorption and has been shown to prevent skin damage from UV and environmental aggressors in the last 3 decades. Is there is value to offering different combinations of Vitamin C-containing antioxidants for different skin types and indications? What can be expected for the range of clinical performance of these antioxidants on different Fitzpatrick skin types? A comprehensive review of the gold standard in antioxidant science, plus new diverse and inclusive clinical data, will be presented.
The case at hand: the chronic hand eczema landscape in 2022
Chronic hand eczema can have a severe impact on quality of life. Although there has been a paucity of approved therapies focused on this condition, there have recent updates to international guidelines and there are a variety of ongoing clinical development programs investigating new treatments. This session will review disease background and burden, the latest guideline updates, and briefly discuss emerging therapies to ensure attendees have the most current information on chronic hand eczema management.
- Review the definition, incidence, and disease burden of chronic hand eczema, highlighting the impact on both patients and to society
- Describe the latest guideline updates related to the prevention and management of chronic hand eczema
- Discuss treatment options and the potential future treatment landscape in light of currently available data
Overview of companies leading Chinese development of medical skin therapies
There has been a dramatic rise in high quality dermatologic scientific research publications originating in China in the past two decades, although this upward migration in knowledge creation has not been translated into therapeutic innovations. However, this is beginning to change. A number of Chinese pharmaceutical companies are making significant progresses in dermatotherapeutics research, and in some cases playing a pioneering role in the world. In this presentation, some of these progresses are described, including how Canada has contributed in, and benefited from, the accelerating skin therapeutics research in China.
Questions & Answers
Breakfast & Visit Sponsors
SM Lectureship: Implications of Genomic Medicine for Dermatology
Professor Whittaker's talk will cover (i) an introduction to the UK strategy for embedding genomic medicine in clinical practice, (ii) specific examples for rare dermatologic disease and skin cancers such as melanoma and cutaneous lymphoma and (iii) future developments such as for common polygenic skin diseases.
Pso Let’s Talk: “The Trouble with Topicals"
Chronic plaque psoriasis (PsO) is an auto-immune mediated inflammatory skin diseases that varies in severity affecting over 1 million people in Canada.1 The majority of patients present with mild to moderate disease as determined by objective measures used by clinicians, but it is increasingly recognized, disease severity experienced by the patient is more than just a body surface area or PASI score calculation as evidenced by decreased quality of life and higher risks for depression, anxiety and suicide.1,2,3 Although topical corticosteroids (TCSs) remain the foundation of treatment and are used across the spectrum of plaque PsO, there has been a paucity of clinical innovation in comparison to the advances in biologic therapies made in the past decade.3,4
Despite good treatment responses with TCSs, they can be limited for long-term use due to local (e.g., stria, skin atrophy, and telangiectasia) or systemic (e.g., hypothalamic-pituitary-adrenal [HPA] axis suppression) adverse events (AEs).5 Topical retinoids and vitamin D analogs, originally introduced in the latter part of the 20th century, have their own troublesome AEs with skin irritation (e.g., redness, itching, stinging or burning, peeling and dryness) as a common cause for a patients’ dissatisfaction and/or lack of adherence.3,5 Topical calcineurin inhibitors and the only currently available topical phosphodiesterase- 4 inhibitor in Canada, are indicated for atopic dermatitis, but have been used for PsO with some success in the sensitive intertriginous and facial areas.6 There is limited access for these latter drugs depending on patients’ private insurance coverage.
PsO is a heterogeneous disease with varied clinical presentations with almost 90% of patients experiencing PsO in more than one location.4,6 Due to the limitations of today’s topical armamentarium, dermatologists often need to prescribe during one patient visit 2 or 3 different topicals of varying potencies and/or formulations. This can be troublesome for patients as they tend to forget or misunderstood the instructions provided by their dermatologist which can be confounded by further troubling instructions from the dispensing pharmacist.3,4 As such, the trouble with topicals today remains and there continues a large unmet need to develop a simplified regimen that is better tolerated with a cosmetically pleasing formulation which is steroid-sparing yet has a fast onset of action with an effectiveness comparable to mid-high potency TCSs. The trek towards this goal will be explored as new developments in topical non-steroid therapy will be presented.
Real-world evidence for dupilumab in atopic dermatitis
Insights into long-term, real-world treatment patterns for AD provide valuable information on current clinical practice and may lead to improvements in clinical decision-making. This presentation will provide an overview of the real-world data on dupilumab’s efficacy and safety from various RWE sources, including registry data base on COVID-19 in AD patients.
Rapid Fire Lunch
Product Ingredient Update
Review contact dermatitis trends to personal care product ingredients, new allergens and industry product labelling changes.
Five Things to Know About Monkeypox
Questions & Answers
Treatment and maintenance of xerotic skin using a once-daily lipid-replenishing cleanser and moisturizer – an open-label, multicenter cohort study
In this session, Nicole Hawkins, MD, FRCPC, will review the results of this open-label, multicenter cohort study demonstrating that a once-daily lipid-replenishing skincare regimen was very well tolerated in subjects prone to skin irritation as well as significantly improved aesthetic signs of xerosis, including skin dryness.
I Can I Am: Reaching New Possibilities with the Canadian and American Clinical Experience with Tildrakizumab
Clinical trial data suggests what can be done (I Can), while clinical experience presents what is possible (I Am). Dr. Parbeer Grewal will provide an overview of what can be done, which will be followed by a panel discussion with Canadian dermatologist Dr. Vim Prajapati and American dermatologist Dr. George Han to understand what is possible based on real-world clinical experience with tildrakizumab through the presentation of patient cases. The session will conclude with an opportunity for the audience to pose questions to the panel.
Challenges in treating plaque psoriasis to target: special sites and managing inadequate response
- Review Canadian treat-to-target recommendations
- Discuss considerations involved in applying treat-to-target principles and criteria to special sites
- Review treatment modification strategies for patients with inadequate response to biologic treatments
Dermatology: Becoming a Procedurally Therapeutic Specialty Over 40 Years
Adjuvant Therapy for High-Risk Melanoma
More than 8000 patients receive the diagnosis of melanoma in Canada each year. Although most of these patients are cured with an excision, those with high-risk melanoma are at increased risk for distant metastasis and death. We will be reviewing current adjuvant treatment options for those patients and the emerging role of adjuvant immunotherapy.